Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
Submitted by
admin
on March 8, 2018 - 11:41pm
Source:
Businesswire
News Tags:
GSK
Europe
labeling
Relvar Ellipta
asthma
Headline:
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
Do Not Allow Advertisers to Use My Personal information
